<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebrovascular disease is one of the most common symptoms associated with anticardiolipin antibodies (ACA) and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA), usually in the form of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, many other <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurologic disorders</z:e> have been described in patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> or ACA </plain></SENT>
<SENT sid="2" pm="."><plain>So far, the precise relation between the presence of antibodies and the development of the disease in many of these cases remain unknown </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0010534'>Transient global amnesia</z:hpo> (<z:mp ids='MP_0004110'>TGA</z:mp>) is an infrequent neurologic disturbance whose precise pathophysiology is not known </plain></SENT>
<SENT sid="4" pm="."><plain>It is characterized by a sudden inability to acquire new information, usually lasting no more than 12 h, and it is not accompanied by any other focal neurological signs or symptoms </plain></SENT>
<SENT sid="5" pm="."><plain>We report a patient with <z:mp ids='MP_0004110'>TGA</z:mp> with persistent and high levels of ACA and LA and suggest that in patients with <z:mp ids='MP_0004110'>TGA</z:mp>, investigation of the possible presence of ACA and/or LA may be warranted because a higher prevalence of <z:mp ids='MP_0004110'>TGA</z:mp> in the patients with antiphospholipidic syndrome with respect to the general population may lead to further insights into pathogenesis of neurologic disease associated with antiphospholipidic antibodies </plain></SENT>
</text></document>